Biotech companies and startups in San Francisco and the Bay Area hiring now

Benchling

San Francisco, US · Series F

Benchling is the AI platform for biotech R&D. Scientists use Benchling to design experiments, capture structured data, and run AI agents and models directly in their workflows. Over 200,000 scientists around the world trust Benchling to power their most important work, from academic labs to Sanofi, Moderna, and more than half of the world's top 50 biopharma.

30 open roles9% remote

Vaxcyte

Vaxcyte uses its licensed cell-free protein synthesis platform to make vaccines.

21 open roles0% remote

Arc Institute

Palo Alto, US

Arc Institute conducts biological research and develops tools for scientists. Its cellular datasets support work on disease biology and computational models.

20 open roles

Radical Numerics

San Francisco, US · Seed

Radical Numerics is an AI research lab building general biological intelligence. Its team created Evo and Evo 2, generative genomics models used to create real gene-editing tools and the first whole genomes designed entirely by AI.

13 open roles0% remote

Alamar Biosciences

Alamar Biosciences provides a platform to detect biomarkers with ultra-high sensitivity. The platform helps researchers examine protein biomarkers across disease states.

12 open roles67% remote

Insitro

South San Francisco, US · Series C

Insitro is a drug discovery and development company using machine learning and data at scale to decode biology for transformative medicines. Its platform generates multi-modal cellular data and high-content phenotypic human cohort data to develop ML-driven predictive disease models.

10 open roles0% remote

Formation Bio

New York, US · Series D

Formation Bio acquires clinical-stage drugs from pharmaceutical and biotech companies and develops them faster using a proprietary tech-driven platform. The company is building an AI-native platform that integrates biomedical data to guide asset selection, accelerate development, and optimize clinical trial execution.

7 open roles0% remote

Octant Bio

Octant Bio develops small molecules to treat protein misfolding and mistrafficking diseases.

5 open roles0% remote

Eikon Therapeutics

Hayward, US · Series D

Eikon Therapeutics is a late-stage clinical biopharmaceutical company advancing a pipeline of potential therapies for patients with unmet medical needs. The company develops medicines using live-cell resolution microscopy and engineering for drug discovery.

5 open roles0% remote

Culture Biosciences

San Francisco, US · Series C

Culture Biosciences simplifies and accelerates bioprocess development to enable customers to bring biopharmaceutical products to market faster. The company has developed a platform that merges products, services, and data management for upstream cell culture process development, applicable to mammalian, microbial, and viral vector production processes. This platform enables high-throughput process development projects to be executed by customers in their own facilities, in Culture's service laboratories, or both, driven by a cloud-connected web application for designing, managing, and analyzing experiments.

4 open roles50% remote

Glyphic Biotechnologies

Series A

Glyphic Biotechnologies, Inc. is developing the first truly de novo high-throughput proteome sequencing technology capable of discriminating all 20 AAs and PTMs accurately with single molecule sensitivity.

4 open roles

GenBio AI

GenBio AI develops AI models to simulate biological systems. Its models support drug discovery and biomedical research.

4 open roles0% remote

Arcadia Science

Arcadia Science uses evolution to inform drug development. It tests a drug discovery model that combines computational prediction and experimental validation.

4 open roles

Ultima Genomics

Newark, US · Series A

Ultima Genomics is a developer of a low-cost sequencing platform.

4 open roles40% remote

Azalea Therapeutics

Azalea Therapeutics develops precision genome engineering inside the body. It uses genome editing tools to engineer T cells inside the patient.

4 open roles

General Proximity

san francisco, US

The company's first wave of drug candidates are focused on oncology, cardiometabolic disease, neurodegenerative diseases, and longevity.

3 open roles

Ansa Biotechnologies

Emeryville, US · Series B

The company offers complex DNA synthesis products including clonal DNA up to 50 kb and linear double-stranded DNA fragments.

3 open roles

Addition Therapeutics

Addition Therapeutics develops genetic medicines for chronic and rare diseases. It uses an all-RNA, non-viral PRINT platform to develop one-time therapies.

3 open roles

Gordian Biotechnology

Gordian Biotechnology starts drug discovery in animals that represent human patients.

3 open roles

Latent Labs

London, GB · Series A

Latent Labs builds AI foundation models to make biology programmable. It enables biotech and pharmaceutical companies to generate and optimize proteins.

3 open roles0% remote

Orca Bio

Menlo Park, US · Series F

Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of blood cancer and autoimmune diseases. Its manufacturing platform uses single-cell precision to create personalized cell therapy products intended to replace a patient's diseased blood and immune system with a healthy one.

3 open roles33% remote

Topos Bio

San Francisco, US

Topos Bio is an AI-powered biotechnology company developing therapies for intrinsically disordered proteins (IDPs). Its platform integrates physics with generative AI to target proteins involved in neurodegeneration, oncology, and metabolic diseases.

2 open roles

Epicrispr Biotechnologies

Epicrispr Biotechnologies develops gene-modulating therapies for neuromuscular diseases.

2 open roles

Onyx Bio

Berkeley, US

Onyx is building a virtual immune system for faster and safer development of precision medicines. Its research generates longitudinal multiomics data anchored in clinical context to profile autoimmune diseases.

2 open roles

Tetsuwan Scientific

Our software platform for automated experimentation is ResearchOS. It combines our proprietary compiler with a model capable of converting written language into the DSLs our compiler communicates in.

2 open roles

Tahoe

South San Francisco, US · Series A

Tahoe Therapeutics is a biotechnology company using its Mosaic in vivo drug discovery platform and next generation AI models to uncover better drugs for more patients. The Mosaic platform is the first to make in vivo data generation scalable, with single-cell precision, to capture in vivo context of disease at the first step of drug discovery.

2 open roles

Retro Biosciences

Redwood City, US

Retro Biosciences develops therapies that meaningfully reverse age-related diseases. The company focuses on cellular reprogramming and autophagy to rejuvenate cell and tissue function.

2 open roles

Rezo Therapeutics

San Francisco, US · Series A

Rezo Therapeutics is a biopharma company that builds a disease-agnostic, fully-integrated, network biology platform to increase the success rate of drug development. The company's Sequence to Systems to Drugs (SSD) platform integrates proteomics, genetics, structural biology, and chemical biology data to create maps of molecular disease networks and identify novel druggable targets.

2 open roles

Karius

Redwood City, US

Karius is a life science, venture-backed clinical metagenomics company focused on elevating patient care through microbial insights. The company's test detects microbial cell-free DNA circulating in the body to assist physicians in making rapid treatment decisions for infectious diseases.

2 open roles86% remote

The EVERY Company

Series D

The EVERY Company creates egg proteins at scale using fermentation and a patented process. Its protein ingredients provide the functionality of eggs.

1 open roles